News
Latest news
-
9 Oct 2026
Nobel Prize-recognized technique available through MultiPark infrastructures
This year’s Nobel Prize in Physiology or Medicine recognizes discoveries behind optogenetics. The technique has a long history in Lund neuroscience, including early Parkinson’s dis...
-
8 Oct 2026
Research on the needs of Parkinson’s patients and their family members receives award
Monica Scharfenort’s research highlights what people with Parkinson’s disease and people close to them need throughout the different stages of the disease – from initial treatment ...
-
2 Oct 2026
Alzheimer’s disease and aging reshape brain communication in different ways
Both normal aging and Alzheimer’s change how different brain regions communicate with each other. But a new study from Lund University reveals that these alterations follow distinc...
-
29 Sep 2026
MultiPark met dementia care professionals at Skånska Demensdagen
Last week, MultiPark participated at Skånska Demensdagen to share knowledge about current research and meet people working with dementia across different parts of society.
-
24 Sep 2026
SEK 190 million for research and development of a new diagnostic test for Alzheimer’s disease
Alzheimer’s researcher Sebastian Palmqvist has been awarded USD 19.4 million (SEK 190 million) from the US National Institutes of Health (NIH), through its National Institute on Ag...
-
17 Sep 2026
Newly discovered link between “jumping genes” and brain inflammation in Parkinson’s disease
One of MultiPark’s research groups led by Professor Johan Jakobsson has uncovered a previously unknown link between inflammatory responses and the activation of repetitive DNA elem...
-
11 Sep 2026
The retina – a future window into Alzheimer’s disease?
Visual dysfunction is increasingly recognized as a feature of Alzheimer's disease. Yet the molecular basis of retinal changes had remained poorly defined, and no previous study has...
-
1 Sep 2026
World Alzheimer’s Month: How MultiPark research contributes to understanding, diagnosing and treating Alzheimer’s disease
New biomarkers can make Alzheimer’s disease easier to detect and diagnoses more accurate, which may be crucial as disease-modifying treatments are available. And the diagnostic too...